Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: The effect of erythromycin

Gut

Volumn 43, Issue 6, 1998, Pages 817-822

  Xu, Q W ^a   Scott, R B ^a   Tan, D T M ^a   Shaffer, E A ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

Cholesterol saturation index; Erythromycin; Gallstone disease; Intestinal transit; Migrating myoelectrical complex

Indexed keywords

BILE SALT; CHOLESTEROL; ERYTHROMYCIN STEARATE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE COMPOSITION; CHOLESTEROL DIET; CHOLESTEROL STONE; CONTROLLED STUDY; DRUG EFFECT; ENTEROHEPATIC CIRCULATION; GALLBLADDER MOTILITY; INTESTINE TRANSIT TIME; LIPID COMPOSITION; MIGRATING MYOELECTRIC COMPLEX; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SQUIRREL;

EID: 0031736775     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.6.817     Document Type: Article

References (51)

1. Grundy SM, Metzger AL, Adler RD. Mechanisms of lithogenic bile formation in American Indian women with cholesterol gallstones. J Clin Invest 1972;51:3026-43.
2. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977;59:828-40.
3. Paumgartner G, Sauerbruch T. Gallstones: pathogenesis. Lancet 1991;338:1117-21.
4. Carey MC. Formation and growth of cholesterol gallstone: the new synthesis. In: Fromm H, Leuschner Y, eds. Bile acids - cholesterol gallstones (Falk symposium No. 84). Dordrecht: Kluwer, 1996:147-75.
5. Pomeranz IS, Shaffer EA. Abnormal gall bladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985;88:787-91.
6. Jazrawi RP, Pazzi P, Petroni ML, et al. Postprandial gall bladder motor function: refilling and turnover of bile in health and in cholelithiasis. Gastroenterology 1995;109:582-91.
7. Heaton KW, Emmett PM, Symes CL, et al. An explanation for gallstones in normal-weight women: slow intestinal transit. Lancet 1993;341:8-10.
8. Shoda J, He B-F, Tanaka N, et al. Increase of deoxycholate in supersaturated hile of patients with cholesterol gallstone disease and its correlation with de novo synthesis of cholesterol and bile acids in liver, gall bladder emptying and small intestinal transit. Hepatology 1995;21:1291-302.
9. Dowling RH, Hussaini SH, Murthy GM, et al. Gallstones during octreotidc therapy. Metabolism 1992;41:22-33.
10. Dowling RH, Veysey MJ, Pereira SP, et al. Role of intestinal transit in the pathogenesis of gall bladder stones. Can J Gastroenterol 1997;11:57-64.
11. Stolk MFJ, van Erpecum KJ, Smout AJPM, et al. Motor cycles with phase III in antrum are associated with high motilin levels and prolonged gall bladder emptying. Am J Physiol 1993;264:G590-600.
12. O'Donnell LJD, Wilson P, Guest P, et al. Indomethacin and postprandial gall bladder emptying. Lancet 1992;339:269-70.
13. Xu QW, Shaffer EA. The potential site of impaired gall bladder contractility in an animal model of cholesterol gallstone disease. Gastroenterology 1996;110:251-7.
14. Xu QW, Scott RB, Tan D, et al. Slow intestinal transit: a motility disorder contributing to cholesterol gallstone formation in the ground squirrel. Hepatology 1996;23: 1664-72.
15. Szurzewski JH. Electrical basis of gastrointestinal motility. In: Johnson LR, ed. Physiology of the gastrointestinal tract. 2nd edn. New York: Raven Press, 1987:383-422.
16. Christensen J. Motility of the intestine. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease. 5th edn. Philadelphia: Saunders, 1993;822-37.
17. Scott RB, Strasberg SM, El-Sharkawy TY, et al. Fasting canine biliary secretion and sphincter of Oddi. Gastroenterology 1984;87:793-804.
18. Scott RB, Eidt PB, Shaffer EA. Regulation of the fasting canine duodenal bile acid delivery by sphincter of Oddi and gall bladder. Am J Physiol 1985;249:G622-33.
19. Carey MC, Duane WC. Enterohepatic circulation. In: Arias IM et al, eds. The liver: biology and pathobiology. 3rd edn. New York: Raven Press, 1994:719-68.
20. Everson GT, Lawson MJ, McKinley C. Gall bladder and small intestinal regulation of biliary lipid secretion during intraduodenal infusion of standard stimuli. J Clin Invest 1983;71:596-603.
21. Itoh Z, Nakaya M, Suzuki T, et al. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol 1984;247:G688-94.
22. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993;88:1886-99.
23. Tomomasa T, Kuroume T, Arai H, et al. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 1986;31:157-61.
24. Catnach SM, Fairclough PD, Trembach RC, et al. Effect of oral erythromycin on gall bladder motility in normal subjects and subjects with gallstones. Gastroenterology 1992;102:2071-6.
25. Scott RB, Diamant SC, Gall DG. Motility effect of intestinal anaphylaxis in the rat. Am J Physiol 1988;255: G505-11.
26. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945-55.
27. MacPherson BR, Pemsingh RS, Scott GW. Experimental cholelithiasis in the ground squirrel. Lab Invest 1987;56: 138-45.
28. Yu P, Chen Q, Biancani P, Behar J. Membrane cholesterol alters gall bladder muscle contractility in prairie dogs. Am J P Physiol 1996;271:G56-61.
29. Berr F, Stellaard F, Pratschke E, Paumgartner G. Effects of cholecystectomy on the kinetics of primary and secondary bile acids. J Clin Invest 1989;83:1541-50.
30. Marcus SN, Heaton KW. Deoxycholic acid and the pathogenesis of gallstones. Gut 1988;29:522-33.
31. Hofmann AF. Bile acids. In: Arias IM, et al, eds. The liver: biology and pathobiology. 2nd edn. New York: Raven Press, 1988:553-72.
32. Metzger AL, Adler R, Heymsfield S, et al. Diurnal variation in biliary lipid composition. Possible role in cholesterol gallstone formation. N Engl J Med 1973;288:333-6.
33. Kim JH, Klyachkin ML, Svendsen E, et al. Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Urol 1994;151:198-205.
34. Kern F, Jr. Effect of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones. J Clin Invest 1994;93:1186-94.
35. Chen Q, Yu P, Biancani P, Behar J. Excess membrane cholesterol alters membrane fluidity of gall bladder muscle cells [abstract]. Gastroenterology 1996;110:A451.
36. Broderick R, Bialecki R, Tulenko T. Cholesterol-induced changes in rabbit arterial smooth muscle sensitivity to adrenergic stimulation. Am J Physiol 1989;257:H170-8.
37. Bialecki RA, Tulenko TN. Excess membrane cholesterol alters calcium channels in arterial smooth muscle. Am J Physiol 1989;257:C306-14.
38. Cox RH, Tulenko TN. Altered contractile and ion channel function in rabbit portal vein with dietary atherosclerosis. Am J Physiol 1905;268:H2522-30.
39. Nilsell K, Angelin B, Liljeqvist L. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients. Gastroenterology 1985;89:287-93.
40. Roda A, Grigolo B, Pellicciari R, et al. Structure-activity relationship studies on natural and synthetic bile acid analogs. Dig Dis Sci 1989;34(suppl):24-35S.
41. Lillemoe KD, Kidder GW, Harmon JW, et al. Tauroursodeoxycholic acid is less damaging than taurochenodeoxycholic acid to the gastric and esophageal mucosa. Dig Dis Sci 1983;28:359-64.
42. Schmucker DL, Ohta M, Kanai S, et al. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990;12:1216-21.
43. Shoemaker DG, Nichols JW. Hydrophobic interaction of lysophospholipids and bile salts at submicellar concentrations. Biochemistry 1990;29:5837-42.
44. Heuman DM, Bajaj R. Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology 1994;106:1333-41.
45. Xu Q-W, Shaffer EA. The influence of bile salts on small intestinal motility in the guinea pig in vitro. Gastroenterology 1992;103:29-35.
46. Xu Q-W, Shaffer EA. Inhibitory effect of bile salts on gall bladder smooth muscle contractility in the guinea pig in vitro. Gastroenterology 1997;112:1699-706.
47. Scott RB, Strasberg SM, El-Sharkawy TY, et al. Regulation of the fasting enterohepatic circulation of bile acids by the migrating myoelectric complex in dogs. J Clin Invest 1983; 71:644-54.
48. Roslyn JJ, DenBesten L, Pitt H, et al. Effect of cholecystokinin on gall bladder stasis and cholesterol gallstone formation. J Surg Res 1981;30:200-4.
49. Doty JE, Pitt HA, Porter-Fink V, et al. Cholecystokinin prophylaxis of parenteral nutrition-induced gall bladder disease. Am Surg 1985;201:76-80.
50. Xu Q-W, Shaffer EA. Cisapride improves gall bladder contractility and bile lipid composition in an animal model of gallstone disease. Gastroenterology 1993;105:1184-91.
51. Xu QW, Scott RB, Tan D, et al. Erythromycin as a prokinetic agent in an animal model of cholesterol gallstone disease [abstract]. Gastroenterology 1995;108:A441.